Aims/background-Adhesion molecules play a key role in the selective recruitment of diVerent leucocyte population to inflammatory sites. The purpose of the present study was to investigate the presence and distribution of adhesion molecules in the conjunctiva of patients with vernal keratoconjunctivitis (VKC). Methods-The presence and distribution of adhesion molecules were studied in 14 conjunctival biopsy specimens from seven patients with active VKC and in four normal conjunctival biopsy specimens. We The molecular basis for the selective migration and accumulation of the diVerent inflammatory cells observed in VKC has not yet been defined. Recently, it has been shown that leucocyte adhesion is a mandatory event in the pathogenesis of an inflammatory response. Leucocytes must adhere to the endothelium in order to migrate to the inflammatory focus. Lymphocytes must also adhere to antigen presenting cells, and antigen bearing target cellsso that normal immunological responsescan occur. Adhesion is regulated by adhesion molecules on circulating leucocytes, and these molecules bind to their ligands on vascular endothelial cells and on target cells. The cell adhesion molecules are classified into three major families: (a) the integrins, (b) the immunoglobulin gene superfamily, and (c) the selectins. Integrins are heterodimers consisting of non-covalently linked and subunits with an extracellular ligand binding site and an intracellular portion linked to the cytoskeleton. This group is subdivided into various families according to the associated subunit. Very late activation antigen-4 (VLA-4) is a 1 integrin. Lymphocyte function associated antigen-1 (LFA-1) is a 2 integrin. Members of the immunoglobulin gene superfamily VLA-4 = very late activation antigen-4; LFA-1 = lymphocyte function associated antigen-1; ICAM-1 = intercellular adhesion molecule-1; ICAM-3 = intercellular adhesion molecule-3, VCAM-1 = vascular cell adhesion molecule-1; ELAM-1 = endothelial leucocyte adhesion molecule-1; MHC = major histocompatibility complex. OKT4 and Leu3a were applied simultaneously.
+ , and IgE + plasma cells,T lymphocytes, macrophages, dendriticcells, and dendritic cells bearing IgE. 1 2 The molecular basis for the selective migration and accumulation of the diVerent inflammatory cells observed in VKC has not yet been defined. Recently, it has been shown that leucocyte adhesion is a mandatory event in the pathogenesis of an inflammatory response. Leucocytes must adhere to the endothelium in order to migrate to the inflammatory focus. Lymphocytes must also adhere to antigen presenting cells, and antigen bearing target cellsso that normal immunological responsescan occur. Adhesion is regulated by adhesion molecules on circulating leucocytes, and these molecules bind to their ligands on vascular endothelial cells and on target cells. 3 The cell adhesion molecules are classified into three major families: (a) the integrins, (b) the immunoglobulin gene superfamily, and (c) the selectins. Integrins are heterodimers consisting of non-covalently linked and subunits with an extracellular ligand binding site and an intracellular portion linked to the cytoskeleton. This group is subdivided into various families according to the associated subunit. Very late activation antigen-4 (VLA-4) is a 1 integrin. Lymphocyte function associated antigen-1 (LFA-1) is a 2 integrin. Members of the immunoglobulin gene superfamily The purpose of this study was to determine the in situ expression of adhesion molecules in conjunctival biopsy specimens from patients with active VKC and to relate the observations to the inflammatory cell infiltrate.
Patients and methods

PATIENTS
Seven consecutive patients with severe active VKC seen at the outpatient clinic of King Abdulaziz University Hospital were included in this study. All the patients were males and their ages ranged from 7 to 15 years, with a mean age of 11 years. The symptoms mentioned by all the patients were itching, redness, photophobia, and tearing. Each patient underwent complete ophthalmic examination, and the corneal and conjunctival changes were noted and recorded. All patients had the palpebral form of the disease characterised by the presence of giant polygonal flat topped cobblestone papillae aVecting the upper palpebral conjunctiva. Upper palpebral conjunctival biopsy specimens were obtained from both eyes of each patient. None of the patients was on topical therapy before obtaining the biopsy. In addition, four conjunctival biopsy specimens were obtained from patients undergoing cataract extraction or operations for retinal detachment without obvious inflammation and these served as controls. The controls were from the same age group. This study was approved by the Research Center, College of Medicine, King Saud University and the patients admitted to the study gave their informed consent.
IMMUNOHISTOCHEMICAL STAINING
The conjunctival biopsy specimens were immediately snap frozen in Tissue-Tek optimum cutting temperature (OCT) compound (Miles Laboratories, IN, USA) and maintained at −80°C until use. Cryostat sections were cut and stained with haematoxylin and eosin for routine histology. For immunohistochemistry, 5 µm serially cut cryostat sections were dried overnight at room temperature, fixed in absolute acetone for 10 minutes, and stained with a three step avidin/biotin peroxidase labelled complex procedure. Rehydrated slides were incubated for 30 minutes with the mouse monoclonal antibodies listed in Table 1 which were diluted to an optimum concentration. The secondary and tertiary antibodies consisted of biotin conjugated rabbit antimouse immunoglobulin and the avidin/biotin peroxidase labelled complex, respectively, which were both purchased from Dakopatts A/S (Copenhagen, Denmark). All incubations were carried out for 30 minutes at room temperature, then washed in three changes of phosphate buVered saline at pH 7.2 for 15 minutes. The reaction product was visualised by incubation for 10 minutes in 0.05 M acetate buVer at pH 4.9, containing 0.05% 3-amino-9-ethyl-carbazole and 0.01% hydrogen peroxide, resulting in bright red immunoreactive sites. The slides were faintly counterstained with Harris haematoxylin. Finally, the sections were rinsed with distilled water and coverslipped with glycerol. Controls, which were invariably negative, consisted of omission of primary or secondary antibody and use of chromogen alone.
Cells were counted in five representative fields. We used an eyepiece calibrated grid with ×25 magnification. With this magnification and calibration we counted the cells present in an area of 0.155 × 0.155 mm. Means (SD) were calculated for each cell type in VKC and control specimens. The t test for independent groups was used to analyse the statistical significance of diVerences between mean values. The diVerences were considered significant if p value was <0.05.
Results
LIGHT MICROSCOPY
All biopsies showed comparable changes characteristic of the disease. The conjunctival surface appeared irregular and thrown into folds covered by a well preserved hyperplastic epithelium showing reticular acanthosis and infiltrated by mononuclear cells, eosinophils, and mast cells. The density of the infiltrating cells was lower in the epithelium than in the stroma. The underlying stroma showed oedema and a heavy inflammatory infiltrate that was concentrated just beneath the epithelium and in the perivascular areas. The stromal inflammatory infiltrate was organised as a diVuse infiltrate and as small lymphoid follicles without reactive centres. The diVuse infiltrate consisted of mononuclear cells, eosinophils, and mast cells. The stromal blood vessels were lined by prominent endothelium and surrounded by inflammatory cells.
IMMUNOHISTOCHEMISTRY
Normal conjunctival biopsy specimens
Conjunctival epithelial cells were negative for HLA-DR antigens. HLA-DR + mononuclear cell were noted in the basal layers of the epithelium and in the superficial stroma just beneath the epithelium. Some of the intraepithelial cells were dendritic Langerhans cells. The vascular endothelial cells expressed HLA-DR antigens. KP1 + macrophages were noted in the basal epithelial layers and in the superficial stroma. T lymphocytes were present in the basal epithelium and in the superficial stroma. In the epithelium OKT8 + cells predominated over OKT4-Leu3a + cells, whereas in the stroma OKT4-Leu3a Weak ICAM-1 expression was noted only on the vascular endothelium mainly in the superficial stroma (Fig 1) . LFA-1 (Fig 2) and ICAM-3 (Fig 3) were expressed on mononuclear cells in the basal epithelium and in the superficial stroma. VLA-4 was found only on few mononuclear cells in the superficial stroma. ELAM-1 and VCAM-1 expression was not detected.
Conjunctival specimens from VKC patients
Similar findings were noted in all biopsy specimens. The density of the inflammatory infiltrate in the conjunctival biopsy specimens from VKC patients was greater than that in normal Table 2 , and a summary is given in All the specimens showed strong ICAM-1 expression on the basal layer of the conjunctival epithelium and on the vascular endothelium of all blood vessels. Furthermore, mononuclear cells in the diVuse stromal infiltrate, and lymphocytes in the lymphoid follicles expressed ICAM-1 (Fig 4) . LFA-1 (Fig 5) and ICAM-3 ( Fig 6) were expressed on the majority of epithelial and stromal mononuclear cells and on the majority of lymphocytes in the lymphoid follicles. Mononuclear cells in the diffuse stromal infiltrate expressed VLA-4. VLA-4 was not expressed on the lymphocytes in the lymphoid follicles. Compared with controls, VKC specimens showed statistically significant more ICAM-3 + , LFA-1 + , and VLA-4 + cells. Weak expression of ELAM-1 (Fig 7) and VCAM-1 (Fig 8) was noted on the vascular endothelium mainly in the superficial stroma.
Discussion
In the normal conjunctiva, ICAM-1 was primarily confined to a low level of cell surface expression on the vascular endothelium. Our observations were consistent with previous reports that ICAM-1 was expressed only on the vascular endothelial cells in normal conjunctiva, 7 normal skin, 8 and normal mucosa of the colon and small intestine. 9 Compared with normal conjunctiva, the conjunctiva from patients with active VKC, showed strong expression of ICAM-1 on the basal epithelial cells and vascular endothelial cells. Furthermore, stromal mononuclear cells were ICAM-1 positive. ICAM-1 mediates the adhesion of T cells to antigen presenting cells or target cells and is also involved in T cell to T cell and T cell to B cell interactions. Binding of ICAM-1 has a costimulatory eVect on T cell activation. In addition, ICAM-1 is important in the adhesion of monocytes, lymphocytes, and neutrophils to activated endothelium. 3 10 It has been shown that expression of ICAM-1 can be induced or upregulated severalfold by inflammatory cytokines including interferon gamma (IFN-), interleukin 1 (IL-1 ), and tumour necrosis factor (TNF-). 8 11-13 Similarly, ICAM-1 upregulation was notedin skin biopsies from patients with allergic dermatoses, 8 14 15 bronchial biopsies from patients with intrinsic and extrinsic asthma, 16 17 and nasal mucosal biopsies from patients with allergic rhinitis. 18 19 LFA-1 which interacts with ICAM-1 was strongly expressed on the majority of inflammatory mononuclear cells in the conjunctival epithelium and stroma in VKC. These mononuclear cells were often closely apposed to ICAM-1 positive vascular endothelial cells and epithelial cells. ICAM-1 plays a critical role in leucocyte adhesion by acting as the ligand for LFA-1 constitutively expressed by lymphocytes, neutrophils, monocytes, and macrophages. 3 20 21 Our results suggest that the interaction of ICAM-1 with LFA-1 may be crucial for the migration of inflammatory cells in the conjunctival stroma and epithelium and the development of conjunctival inflammation in VKC. Moreover, ICAM-1 expression by basal epithelial cells may be an important initiator of epithelial cell-lymphocyte interactions by means of LFA-1/ICAM-1 interactions.
In sharp contrast with our results for ICAM-1, we found that there was no expression of HLA-DR antigens by the epithelial cells. This shows that the expressions of ICAM-1 and HLA-DR are probably regulated diVerently. Similar diVerences between the expression of ICAM-1 and HLA-DR antigens on epithelial cells were previously shown in some inflammatory dermatoses, 8 14 15 in which keratinocytes expressed ICAM-1 but no HLA-DR antigens. It is well known that the expression of HLA-DR antigens requires stimulation with IFN- 8 22 23 produced by activated T cells. Our findings suggest, therefore, that this immunoregulatory cytokine may not play a major role in the pathophysiology of VKC. This is despite the fact that a high density of activated T cells expressing HLA-DR antigens predominantly of the helper/inducer subset have been observed in the conjunctival epithelial and stromal infiltrate in VKC. Two diVerent types of helper/inducer T cell clones have been identified. The TH1 cells secrete IL-2, IFN-, and TNF while TH2 cells secrete IL-3, IL-4, IL-5, IL-6, and IL-10. The TH1 responses are characterised by strong cell mediated immunity and often only a modest humoral response. In contrast, TH2 responses are usually associated with high titre antibody responses, but poor delayed type hypersensitivity reactions. 24 Thus, it is proposed that in patients with VKC, the putative antigens may predominantly stimulate TH2 cells which do not produce IFN-, an important inducer of HLA-DR antigens. IL-3 and IL-4, products of TH2 cells, regulate the proliferation of mast cells. 25 26 IL-4 was also shown to induce IgE switching and IgE synthesis by B cells. 27 Our results for HLA-DR when taken into consideration with those for ICAM-1 imply that TNF-and IL-1 rather than IFN-are among the more significant immune associated inflammatory mediators in VKC. This view is strengthened by the fact that macrophages presumably capable of producing TNF-and IL-1 28 are present in abundance in both the conjunctival epithelium and stroma in VKC. In addition, it was shown that mast cell degranulation results in TNF-and IL-1 release. 29 30 ICAM-3 was expressed on the majority of mononuclear cells infiltrating the conjunctival epithelium and stroma in VKC. ICAM-3 is constitutively expressed on monocytes, granulocytes, and the majority of lymphocytes, but not on normal or activated endothelial cells. 31 Quantitative functional data suggested that ICAM-3 is the major counter receptor for LFA-1 on all resting leucocytes. 32 Recent data implicate ICAM-3 as an important molecule involved in the activation of resting T cells. It is able to induce homotypic lymphocyte aggregation, both by LFA-1/ICAM-3 dependent and independent pathways, and is costimulatory for T cells. It has been postulated that ICAM-3 could be the initial ligand for LFA-1 during antigen induced leucocyte interactions. 33 In the normal conjunctiva the expression of ELAM-1 and VCAM-1 was virtually nonexistent. This corresponds with results obtained in the normal skin. 34 In contrast, there was a weak expression of ELAM-1 and VCAM-1 on the vascular endothelium in VKC. ELAM-1 and VCAM-1 are induced on endothelial cells by IL-I and TNF-. 35 36 In addition, IL-4 was found to be a selective stimulus for upregulating the expression of VCAM-1 on endothelial cells. 37 . Upon stimulation, mast cells release factors, including TNF-, IL-1, and IL-4 29 30 which can modulate adhesion molecules on endothelial cells. Sialyl Lewis X is a ligand for ELAM-1 and it forms a carbohydrate side chain on L-selectin, found on neutrophil and lymphocyte cell surfaces. L-selectin may, therefore, present sialyl Lewis X to ELAM-1 expressed on activated vascular endothelium. 5 ELAM-1 mediates adherence of neutrophils, monocytes, and some memory T cells to vascular endothelium in the early phase of inflammatory reactions, 35 38-40 hence it is important in the regulation of inflammatory and immunological events at the vessel wall. In the present study, VLA-4 was expressed on mononuclear cells in the stromal infiltrate. VLA-4 expressed on eosinophils, monocytes, and lymphocytes is a ligand for VCAM-1.
41
Because VLA-4 is expressed on eosinophils and not on neutrophils, VCAM-1 is postulated to mediate selective eosinophil recruitment. 19 42 Blocking VCAM-1 with a specific antibody was extremely eVective in inhibiting eosinophil adherence in vitro but had no eVect on neutrophil adherence, supporting the importance of VCAM-1 in the migration of eosinophils but not neutrophils. 42 Ebisawa and associates 43 have shown that the initial attachment of eosinophils to IL-1 activated endothelial cells involves VCAM-1, ELAM-1, and ICAM-1. However, the subsequent transendothelial migration process relies heavily on the expression of CD11/CD18 on eosinophilic granulocytes and of ICAM-1 on endothelial cells. Similarly, a significant expression of ELAM-1, and VCAM-1 was demonstrated in allergic diseases as intrinsic and extrinsic asthma, 16 17 atopic dermatitis, 34 and allergic rhinitis. In conclusion, increased expression of adhesion molecules promotes the recruitment of inflammatory cells through blood vessels and the cell interactions between lymphocytes and antigen presenting cells, among lymphocytes, and between lymphocytes and epithelial cells, thereby sustaining the immunoinflammatory process in VKC. Interfering with such adhesive interactions with monoclonal antibodies directed against adhesion molecules may provide new therapeutic modalities in VKC. 
